Current Ratio of Eledon Pharmaceuticals, Inc. from 30 Jun 2015 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Eledon Pharmaceuticals, Inc. quarterly Current Ratio in % history and change rate from 30 Jun 2015 to 30 Sep 2025.
  • Eledon Pharmaceuticals, Inc. Current Ratio for the quarter ending 30 Sep 2025 was 982%, a 4% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Change (%)

Eledon Pharmaceuticals, Inc. Quarterly Current Ratio (%)

Period Value YoY Chg Change % Date
Q3 2025 982% -41% -4% 30 Sep 2025
Q2 2025 989% -502% -34% 30 Jun 2025
Q1 2025 1121% -389% -26% 31 Mar 2025
Q4 2024 1050% -358% -25% 31 Dec 2024
Q3 2024 1024% -217% -17% 30 Sep 2024
Q2 2024 1490% +411% +38% 30 Jun 2024
Q1 2024 1510% +353% +31% 31 Mar 2024
Q4 2023 1407% -63% -4.3% 31 Dec 2023
Q3 2023 1241% -580% -32% 30 Sep 2023
Q2 2023 1079% -1210% -53% 30 Jun 2023
Q1 2023 1157% -1441% -55% 31 Mar 2023
Q4 2022 1470% -1118% -43% 31 Dec 2022
Q3 2022 1821% -1340% -42% 30 Sep 2022
Q2 2022 2289% -574% -20% 30 Jun 2022
Q1 2022 2598% +77% +3.1% 31 Mar 2022
Q4 2021 2588% +401% +18% 31 Dec 2021
Q3 2021 3161% +1745% +123% 30 Sep 2021
Q2 2021 2862% +2109% +280% 30 Jun 2021
Q1 2021 2520% +1781% +241% 31 Mar 2021
Q4 2020 2186% +1602% +274% 31 Dec 2020
Q3 2020 1417% +862% +155% 30 Sep 2020
Q2 2020 754% 30 Jun 2020
Q1 2020 739% 31 Mar 2020
Q4 2019 585% 31 Dec 2019
Q3 2019 555% 30 Sep 2019
Q3 2017 617% -163% -21% 30 Sep 2017
Q2 2017 556% -402% -42% 30 Jun 2017
Q1 2017 534% -737% -58% 31 Mar 2017
Q4 2016 580% -892% -61% 31 Dec 2016
Q3 2016 780% -1030% -57% 30 Sep 2016
Q2 2016 958% -1027% -52% 30 Jun 2016
Q1 2016 1271% 31 Mar 2016
Q4 2015 1472% 31 Dec 2015
Q3 2015 1810% 30 Sep 2015
Q2 2015 1985% 30 Jun 2015
* An asterisk sign (*) next to the value indicates that the value is likely invalid.